Rubric Capital Management (New York)’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.4M | Buy |
|
|||||
|
2025
Q1 | $89.5M | Buy |
|
|||||
|
2024
Q4 | $67.3M | Buy |
|
|||||
|
2024
Q3 | $48.3M | Sell |
|
|||||
|
2024
Q2 | $75.1M | Buy |
|
|||||
|
2024
Q1 | $71.2M | Sell |
|
|||||
|
2023
Q4 | $84.9M | Sell |
|
|||||
|
2023
Q3 | $71M | Sell |
|
|||||
|
2023
Q2 | $73.6M | Buy |
|
|||||
|
2023
Q1 | $78.5M | Sell |
|
|||||
|
2022
Q4 | $77.3M | Hold |
|
|||||
|
2022
Q3 | $53.4M | Buy |
|
|||||
|
2022
Q2 | $57.7M | Buy |
|
|||||
|
2022
Q1 | $61.1M | Buy |
|
|||||
|
2021
Q4 | $48.7M | Hold |
|
|||||
|
2021
Q3 | $51.5M | Buy |
|
|||||
|
2021
Q2 | $57.2M | Hold |
|
|||||
|
2021
Q1 | $57.4M | Buy |
|
|||||
|
2020
Q4 | $38.6M | Hold |
|
|||||
|
2020
Q3 | $40.1M | Hold |
|
|||||
|
2020
Q2 | $33.7M | Buy |
|
|||||
|
2020
Q1 | $19.8M | Buy |
|